BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33891937)

  • 1. Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis.
    Höflinger P; Hauser S; Yutuc E; Hengel H; Griffiths L; Radelfahr F; Howell OW; Wang Y; Connor SL; Duell PB; DeBarber AE; Martus P; Lütjohann D; Griffiths WJ; Schöls L
    J Lipid Res; 2021; 62():100078. PubMed ID: 33891937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
    J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.
    Huidekoper HH; Vaz FM; Verrips A; Bosch AM
    Eur J Pediatr; 2016 Jan; 175(1):143-6. PubMed ID: 26156051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.
    Griffiths WJ; Crick PJ; Meljon A; Theofilopoulos S; Abdel-Khalik J; Yutuc E; Parker JE; Kelly DE; Kelly SL; Arenas E; Wang Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Feb; 1864(2):191-211. PubMed ID: 30471425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chenodeoxycholic Acid: An Update on Its Therapeutic Applications.
    Fiorucci S; Distrutti E
    Handb Exp Pharmacol; 2019; 256():265-282. PubMed ID: 31267167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots.
    Hong X; Daiker J; Sadilek M; DeBarber AE; Chiang J; Duan J; Bootsma AH; Huidekoper HH; Vaz FM; Gelb MH
    Genet Med; 2020 Oct; 22(10):1606-1612. PubMed ID: 32523054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
    Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M
    J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies.
    Zaccai TCF; Hassin-Baer S; Kfir NC; Duell PB; Neerhof M; Sloma R; Roitman M; Kisanuki YY; Verrips A; DeBarber AE
    Genet Med; 2024 May; 26(5):101086. PubMed ID: 38288684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).
    Salen G; Steiner RD
    J Inherit Metab Dis; 2017 Nov; 40(6):771-781. PubMed ID: 28980151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report.
    Koyama S; Okabe Y; Suzuki Y; Igari R; Sato H; Iseki C; Tanji K; Suzuki K; Ohta Y
    BMC Neurol; 2022 May; 22(1):193. PubMed ID: 35614401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis.
    Majait S; Meessen ECE; Vaz FM; Kemper EM; Nierop SV; Olde Damink SW; Schaap FG; Romijn JA; Nieuwdorp M; Verrips A; Knop FK; Soeters MR
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene supplementation of
    Lumbreras S; Ricobaraza A; Baila-Rueda L; Gonzalez-Aparicio M; Mora-Jimenez L; Uriarte I; Bunuales M; Avila MA; Monte MJ; Marin JJG; Cenarro A; Gonzalez-Aseguinolaza G; Hernandez-Alcoceba R
    Mol Ther Methods Clin Dev; 2021 Sep; 22():210-221. PubMed ID: 34485606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
    Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
    Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.
    Ribeiro RM; Vasconcelos SC; Lima PLGSB; Coelho EF; Oliveira AMN; Gomes EABM; Mota LA; Radtke LS; Carvalho MDS; Araújo DABS; Pinheiro MSN; Gama VCV; Júnior RMM; Braga Neto P; Nóbrega PR
    Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies.
    Verrips A; Dotti MT; Mignarri A; Stelten BML; Verma S; Federico A
    Neurol Sci; 2020 Apr; 41(4):943-949. PubMed ID: 31863326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
    J Biol Chem; 2001 Sep; 276(37):34579-85. PubMed ID: 11454857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.
    Catarino CB; Vollmar C; Küpper C; Seelos K; Gallenmüller C; Bartkiewicz J; Biskup S; Hörtnagel K; Klopstock T
    J Neurol; 2018 Feb; 265(2):388-393. PubMed ID: 29260356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Cerebrotendinous xanthomatosis with a novel mutation in the
    Chun MY; Heo NJ; Seo SW; Jang H; Suh YL; Jang JH; Kim YE; Kim EJ; Moon SY; Jung NY; Lee SM; Kim HJ
    Front Neurol; 2023; 14():1131888. PubMed ID: 36959818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A useful multi-analyte blood test for cerebrotendinous xanthomatosis.
    DeBarber AE; Luo J; Giugliani R; Souza CF; Chiang JP; Merkens LS; Pappu AS; Steiner RD
    Clin Biochem; 2014 Jun; 47(9):860-3. PubMed ID: 24769274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.